Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Gene Therapy market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Gene Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Gene Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Spark Therapeutics
Vical
Advantagene
Celladon
Dimension Therapeutics
Avalanche Bio
Sangamo
By Type:
Ex vivo
In vivo
By End-User:
Cancer Diseases
Monogenic Diseases
Infectious Diseases
Cardiovascular Diseases
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gene Therapy Market
-
1.3 Market Segment by Type
-
1.3.1 Japan Gene Therapy Market Size and Growth Rate of Ex vivo from 2014 to 2026
-
1.3.2 Japan Gene Therapy Market Size and Growth Rate of In vivo from 2014 to 2026
-
1.4 Market Segment by Application
-
1.4.1 Market Size and Growth Rate of Cancer Diseases
-
1.4.2 Market Size and Growth Rate of Monogenic Diseases
-
1.4.3 Market Size and Growth Rate of Infectious Diseases
-
1.4.4 Market Size and Growth Rate of Cardiovascular Diseases
-
1.4.5 Market Size and Growth Rate of Others
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Gene Therapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gene Therapy by Major Types
-
3.4.1 Japan Gene Therapy Market Size and Growth Rate of Ex vivo from 2014 to 2026
-
3.4.2 Japan Gene Therapy Market Size and Growth Rate of In vivo from 2014 to 2026
4 Segmentation of Gene Therapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gene Therapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Gene Therapy in Cancer Diseases
-
4.4.2 Market Size and Growth Rate of Gene Therapy in Monogenic Diseases
-
4.4.3 Market Size and Growth Rate of Gene Therapy in Infectious Diseases
-
4.4.4 Market Size and Growth Rate of Gene Therapy in Cardiovascular Diseases
-
4.4.5 Market Size and Growth Rate of Gene Therapy in Others
5 Market Analysis by Regions
-
5.1 Japan Gene Therapy Production Analysis by Regions
-
5.2 Japan Gene Therapy Consumption Analysis by Regions
6 Hokkaido Gene Therapy Landscape Analysis
-
6.1 Hokkaido Gene Therapy Landscape Analysis by Major Types
-
6.2 Hokkaido Gene Therapy Landscape Analysis by Major End-Users
7 Tohoku Gene Therapy Landscape Analysis
-
7.1 Tohoku Gene Therapy Landscape Analysis by Major Types
-
7.2 Tohoku Gene Therapy Landscape Analysis by Major End-Users
8 Kanto Gene Therapy Landscape Analysis
-
8.1 Kanto Gene Therapy Landscape Analysis by Major Types
-
8.2 Kanto Gene Therapy Landscape Analysis by Major End-Users
9 Chubu Gene Therapy Landscape Analysis
-
9.1 Chubu Gene Therapy Landscape Analysis by Major Types
-
9.2 Chubu Gene Therapy Landscape Analysis by Major End-Users
10 Kinki Gene Therapy Landscape Analysis
-
10.1 Kinki Gene Therapy Landscape Analysis by Major Types
-
10.2 Kinki Gene Therapy Landscape Analysis by Major End-Users
11 Chugoku Gene Therapy Landscape Analysis
-
11.1 Chugoku Gene Therapy Landscape Analysis by Major Types
-
11.2 Chugoku Gene Therapy Landscape Analysis by Major End-Users
12 Shikoku Gene Therapy Landscape Analysis
-
12.1 Shikoku Gene Therapy Landscape Analysis by Major Types
-
12.2 Shikoku Gene Therapy Landscape Analysis by Major End-Users
13 Kyushu Gene Therapy Landscape Analysis
-
13.1 Kyushu Gene Therapy Landscape Analysis by Major Types
-
13.2 Kyushu Gene Therapy Landscape Analysis by Major End-Users
14 Major Players Profiles
-
14.1 Spark Therapeutics
-
14.1.1 Spark Therapeutics Company Profile and Recent Development
-
14.1.2 Spark Therapeutics Market Performance
-
14.1.3 Spark Therapeutics Product and Service Introduction
-
14.2 Vical
-
14.2.1 Vical Company Profile and Recent Development
-
14.2.2 Vical Market Performance
-
14.2.3 Vical Product and Service Introduction
-
14.3 Advantagene
-
14.3.1 Advantagene Company Profile and Recent Development
-
14.3.2 Advantagene Market Performance
-
14.3.3 Advantagene Product and Service Introduction
-
14.4 Celladon
-
14.4.1 Celladon Company Profile and Recent Development
-
14.4.2 Celladon Market Performance
-
14.4.3 Celladon Product and Service Introduction
-
14.5 Dimension Therapeutics
-
14.5.1 Dimension Therapeutics Company Profile and Recent Development
-
14.5.2 Dimension Therapeutics Market Performance
-
14.5.3 Dimension Therapeutics Product and Service Introduction
-
14.6 Avalanche Bio
-
14.6.1 Avalanche Bio Company Profile and Recent Development
-
14.6.2 Avalanche Bio Market Performance
-
14.6.3 Avalanche Bio Product and Service Introduction
-
14.7 Sangamo
-
14.7.1 Sangamo Company Profile and Recent Development
-
14.7.2 Sangamo Market Performance
-
14.7.3 Sangamo Product and Service Introduction
The List of Tables and Figures (Totals 107 Figures and 199 Tables)
-
Figure Japan Gene Therapy Market Size and Growth Rate of Ex vivo from 2014 to 2026
-
Figure Japan Gene Therapy Market Size and Growth Rate of In vivo from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
-
Figure Market Size and Growth Rate of Cancer Diseases
-
Figure Market Size and Growth Rate of Monogenic Diseases
-
Figure Market Size and Growth Rate of Infectious Diseases
-
Figure Market Size and Growth Rate of Cardiovascular Diseases
-
Figure Market Size and Growth Rate of Others
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Gene Therapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Gene Therapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gene Therapy by Different Types from 2014 to 2026
-
Table Consumption Share of Gene Therapy by Different Types from 2014 to 2026
-
Figure Japan Gene Therapy Market Size and Growth Rate of Ex vivo from 2014 to 2026
-
Figure Japan Gene Therapy Market Size and Growth Rate of In vivo from 2014 to 2026
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Gene Therapy by Different End-Users from 2014 to 2026
-
Table Consumption Share of Gene Therapy by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Cancer Diseases
-
Figure Market Size and Growth Rate of Monogenic Diseases
-
Figure Market Size and Growth Rate of Infectious Diseases
-
Figure Market Size and Growth Rate of Cardiovascular Diseases
-
Figure Market Size and Growth Rate of Others
-
Table Japan Gene Therapy Production by Regions
-
Table Japan Gene Therapy Production Share by Regions
-
Figure Japan Gene Therapy Production Share by Regions in 2014
-
Figure Japan Gene Therapy Production Share by Regions in 2018
-
Figure Japan Gene Therapy Production Share by Regions in 2026
-
Table Japan Gene Therapy Consumption by Regions
-
Table Japan Gene Therapy Consumption Share by Regions
-
Figure Japan Gene Therapy Consumption Share by Regions in 2014
-
Figure Japan Gene Therapy Consumption Share by Regions in 2018
-
Figure Japan Gene Therapy Consumption Share by Regions in 2026
-
Table Hokkaido Gene Therapy Consumption by Types from 2014 to 2026
-
Table Hokkaido Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Gene Therapy Consumption Share by Types in 2014
-
Figure Hokkaido Gene Therapy Consumption Share by Types in 2018
-
Figure Hokkaido Gene Therapy Consumption Share by Types in 2026
-
Table Hokkaido Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Gene Therapy Consumption Share by End-Users in 2014
-
Figure Hokkaido Gene Therapy Consumption Share by End-Users in 2018
-
Figure Hokkaido Gene Therapy Consumption Share by End-Users in 2026
-
Table Tohoku Gene Therapy Consumption by Types from 2014 to 2026
-
Table Tohoku Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Gene Therapy Consumption Share by Types in 2014
-
Figure Tohoku Gene Therapy Consumption Share by Types in 2018
-
Figure Tohoku Gene Therapy Consumption Share by Types in 2026
-
Table Tohoku Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Tohoku Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Gene Therapy Consumption Share by End-Users in 2014
-
Figure Tohoku Gene Therapy Consumption Share by End-Users in 2018
-
Figure Tohoku Gene Therapy Consumption Share by End-Users in 2026
-
Table Kanto Gene Therapy Consumption by Types from 2014 to 2026
-
Table Kanto Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kanto Gene Therapy Consumption Share by Types in 2014
-
Figure Kanto Gene Therapy Consumption Share by Types in 2018
-
Figure Kanto Gene Therapy Consumption Share by Types in 2026
-
Table Kanto Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Kanto Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Gene Therapy Consumption Share by End-Users in 2014
-
Figure Kanto Gene Therapy Consumption Share by End-Users in 2018
-
Figure Kanto Gene Therapy Consumption Share by End-Users in 2026
-
Table Chubu Gene Therapy Consumption by Types from 2014 to 2026
-
Table Chubu Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Chubu Gene Therapy Consumption Share by Types in 2014
-
Figure Chubu Gene Therapy Consumption Share by Types in 2018
-
Figure Chubu Gene Therapy Consumption Share by Types in 2026
-
Table Chubu Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Chubu Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Gene Therapy Consumption Share by End-Users in 2014
-
Figure Chubu Gene Therapy Consumption Share by End-Users in 2018
-
Figure Chubu Gene Therapy Consumption Share by End-Users in 2026
-
Table Kinki Gene Therapy Consumption by Types from 2014 to 2026
-
Table Kinki Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kinki Gene Therapy Consumption Share by Types in 2014
-
Figure Kinki Gene Therapy Consumption Share by Types in 2018
-
Figure Kinki Gene Therapy Consumption Share by Types in 2026
-
Table Kinki Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Kinki Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Gene Therapy Consumption Share by End-Users in 2014
-
Figure Kinki Gene Therapy Consumption Share by End-Users in 2018
-
Figure Kinki Gene Therapy Consumption Share by End-Users in 2026
-
Table Chugoku Gene Therapy Consumption by Types from 2014 to 2026
-
Table Chugoku Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Gene Therapy Consumption Share by Types in 2014
-
Figure Chugoku Gene Therapy Consumption Share by Types in 2018
-
Figure Chugoku Gene Therapy Consumption Share by Types in 2026
-
Table Chugoku Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Chugoku Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Gene Therapy Consumption Share by End-Users in 2014
-
Figure Chugoku Gene Therapy Consumption Share by End-Users in 2018
-
Figure Chugoku Gene Therapy Consumption Share by End-Users in 2026
-
Table Shikoku Gene Therapy Consumption by Types from 2014 to 2026
-
Table Shikoku Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Gene Therapy Consumption Share by Types in 2014
-
Figure Shikoku Gene Therapy Consumption Share by Types in 2018
-
Figure Shikoku Gene Therapy Consumption Share by Types in 2026
-
Table Shikoku Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Shikoku Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Gene Therapy Consumption Share by End-Users in 2014
-
Figure Shikoku Gene Therapy Consumption Share by End-Users in 2018
-
Figure Shikoku Gene Therapy Consumption Share by End-Users in 2026
-
Table Kyushu Gene Therapy Consumption by Types from 2014 to 2026
-
Table Kyushu Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Gene Therapy Consumption Share by Types in 2014
-
Figure Kyushu Gene Therapy Consumption Share by Types in 2018
-
Figure Kyushu Gene Therapy Consumption Share by Types in 2026
-
Table Kyushu Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Kyushu Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Gene Therapy Consumption Share by End-Users in 2014
-
Figure Kyushu Gene Therapy Consumption Share by End-Users in 2018
-
Figure Kyushu Gene Therapy Consumption Share by End-Users in 2026
-
Table Company Profile and Development Status of Spark Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spark Therapeutics
-
Figure Sales and Growth Rate Analysis of Spark Therapeutics
-
Figure Revenue and Market Share Analysis of Spark Therapeutics
-
Table Product and Service Introduction of Spark Therapeutics
-
Table Company Profile and Development Status of Vical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vical
-
Figure Sales and Growth Rate Analysis of Vical
-
Figure Revenue and Market Share Analysis of Vical
-
Table Product and Service Introduction of Vical
-
Table Company Profile and Development Status of Advantagene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advantagene
-
Figure Sales and Growth Rate Analysis of Advantagene
-
Figure Revenue and Market Share Analysis of Advantagene
-
Table Product and Service Introduction of Advantagene
-
Table Company Profile and Development Status of Celladon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celladon
-
Figure Sales and Growth Rate Analysis of Celladon
-
Figure Revenue and Market Share Analysis of Celladon
-
Table Product and Service Introduction of Celladon
-
Table Company Profile and Development Status of Dimension Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dimension Therapeutics
-
Figure Sales and Growth Rate Analysis of Dimension Therapeutics
-
Figure Revenue and Market Share Analysis of Dimension Therapeutics
-
Table Product and Service Introduction of Dimension Therapeutics
-
Table Company Profile and Development Status of Avalanche Bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Avalanche Bio
-
Figure Sales and Growth Rate Analysis of Avalanche Bio
-
Figure Revenue and Market Share Analysis of Avalanche Bio
-
Table Product and Service Introduction of Avalanche Bio
-
Table Company Profile and Development Status of Sangamo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo
-
Figure Sales and Growth Rate Analysis of Sangamo
-
Figure Revenue and Market Share Analysis of Sangamo
-
Table Product and Service Introduction of Sangamo
-
